Live Breaking News & Updates on ஒரினிய மருந்துகள் இன்க்

Stay updated with breaking news from ஒரினிய மருந்துகள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of . ....

United States , United Kingdom , Neil Solomons , Rob Huizinga , Glenn Schulman , Peter Greenleaf , Aurinia Pharmaceuticals Inc , Exchange Commission Electronic Document Gathering , Drug Administration , Riptide Bioscience Inc , Thunderbolt Pharma Inc , Investor Relations Corporate Communications , Chief Executive Officer , Recombinant Fc Protein Targeting , Thunderbolt Pharma , B Cell Activating Factor , Proliferation Inducing Ligand , United State Food , Chief Medical Officer , Riptide Bioscience , Executive Vice President , British Columbia , Annual Report , Canadian Securities Administrator System , Electronic Document Analysis , Exchange Commission ,